Israeli generic drugmaker Teva Pharmaceutical Industries Ltd. agreed Thursday to acquire Mexican pharma company Representaciones e Investigaciones M‚dicas, S.A. de C.V. (Rimsa), in a debt-free, cash free set of deals for an aggregate of $2.3 billion. The deal includes Rimsa’s portfolio of products and companies, intellectual property, assets and pharmaceutical patents in Latin America and Europe.